Surrozen, Inc.
SRZN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001824893
In the last 90 days, Surrozen, Inc. insiders filed 0 open-market purchases and 1 sale; 70 institutions reported holding it in 13F filings for Q2 2026, worth $314.5M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Surrozen, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +3 vs. Q2 2023
- Shares held
- 16.1M
- +449.7K (+2.9%) vs. Q2 2023
- Total value
- $7.90M
- −$719.8K (−8.4%) vs. Q2 2023
- New holders
- 5
- 6 more added
- Sold out
- 2
- 3 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SRZN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 70 | $314.5M |
| Q1 2026 | 59 | $314.2M |
| Q4 2025 | 55 | $195.1M |
| Q3 2025 | 36 | $81.7M |
| Q2 2025 | 31 | $53.9M |
| Q1 2025 | 30 | $63.5M |
| Q4 2024 | 24 | $35.4M |
| Q3 2024 | 23 | $25.5M |
| Q2 2024 | 21 | $23.1M |
| Q1 2024 | 16 | $15.0M |
| Q4 2023 | 17 | $9.78M |
| Q3 2023 | 25 | $7.90M |
| Q2 2023 | 22 | $8.62M |
| Q1 2023 | 23 | $9.91M |
| Q4 2022 | 26 | $9.36M |
| Q3 2022 | 27 | $44.1M |
| Q2 2022 | 24 | $63.1M |
| Q1 2022 | 30 | $67.4M |
| Q4 2021 | 32 | $153.5M |
| Q3 2021 | 29 | $150.7M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Surrozen, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 484 | $0 | 0.00% | −105−17.8% | Reduced |
| JPMorgan Chase & Co | 25 | $12 | 0.00% | +25 | New |
| Wells Fargo & Company | 134 | $66 | 0.00% | +2+1.5% | Added |
| UBS Group AG | 4,761 | $2.33K | 0.00% | +4,761 | New |
| Wolverine Asset Management LLC | 7,725 | $3.79K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 8,738 | $4.28K | 0.00% | +313+3.7% | Added |
| Prudential Financial Inc | 10,000 | $4.90K | 0.00% | −10,600−51.5% | Reduced |
| Virtu Financial LLC | 12,154 | $6.00K | 0.00% | +12,154 | New |
| XTX Topco Ltd | 14,494 | $7.10K | 0.00% | +14,494 | New |
| Northern Trust Corp | 35,833 | $17.6K | 0.00% | 00.0% | Unchanged |
| Bridger Management, LLC | 61,699 | $30.2K | 0.01% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 61,699 | $30.2K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 70,932 | $34.8K | 0.00% | 00.0% | Unchanged |
| BML Capital Management, LLC | 89,271 | $43.7K | 0.04% | −1,369,813−93.9% | Reduced |
| Renaissance Technologies LLC | 124,598 | $61.0K | 0.00% | +10,900+9.6% | Added |
| Geode Capital Management, LLC | 172,148 | $84.4K | 0.00% | +198+0.1% | Added |
| Alyeska Investment Group, L.P. | 305,648 | $149.8K | 0.00% | +305,648 | New |
| Vanguard Group Inc | 487,698 | $239.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 528,180 | $258.8K | 0.00% | 00.0% | Unchanged |
| Trustees of Columbia University in the City of New York | 718,950 | $352.3K | 0.65% | 00.0% | Unchanged |
| Board of Trustees of The Leland Stanford Junior University | 781,960 | $383.2K | 0.03% | 00.0% | Unchanged |
| Harvard Management Co Inc | 826,852 | $405.0K | 0.05% | 00.0% | Unchanged |
| BlackRock Inc. | 1,068,571 | $523.6K | 0.00% | +1,032,372+2,851.9% | Added |
| Euclidean Capital LLC | 1,315,463 | $644.6K | 0.14% | +512,500+63.8% | Added |
| The Column Group LLC | 9,414,795 | $4.61M | 3.06% | 00.0% | Unchanged |
| Jasper Ridge Partners, L.P. | 0 | $0 | 0.00% | −46,838−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −16,271−100.0% | Sold out |